Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review
<正>罗沙司他作为一种里程碑式的新药用于治疗慢性肾脏病(chronic kidney disease,CKD)贫血,临床试验已证实其疗效及安全性,目前临床上已逐渐开始使用。本文报告1例罗沙司他治疗抗中性粒细胞胞质抗体(antineutrophil cytoplasmic antibody,ANCA)相关性血管炎所致CKD贫血患者,该患者在罗沙司他用药前后均使用促红细胞生成素治疗CKD贫血,...
Saved in:
| Main Authors: | Xiao Xiang, Feng Ya, Zhang Ya-lan, Xu Dan, Ma Rong, Mao Nan |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57905582&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01) -
Clinical efficacy and safety analysis in initial hemodialysis patient with renal anemia treated by roxadustat or recombinant human erythropoietin
by: Zhang Peng-jie, et al.
Published: (2022-11-01) -
Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis
by: Ningjun Shao, et al.
Published: (2025-08-01) -
Roxadustat for the treatment of anemia in patients with chronic kidney disease: a Meta-analysis
by: WANG Rui, et al.
Published: (2019-01-01) -
Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
by: Wenhui Wu, et al.
Published: (2024-12-01)